BEUDAMED
    FDA PMA FDA Class 3 Approved 🇺🇸 United States

    Test, Hepatitis B (B Core, Be Antigen, Be Antibody, B Core Igm)

    PMA: P100032 · Supplement: S014 · Decision Aug 16, 2017
    View on FDA
    Classifications
    1
    FEI Numbers
    27
    Registration Numbers
    27

    Basic Information

    Device Name
    Test, Hepatitis B (B Core, Be Antigen, Be Antibody, B Core Igm)
    Trade Name
    Elecsys Anti-HBC Immunoassay test system
    PMA Number
    P100032
    Supplement Number
    S014
    Device Class
    FDA Class 3
    Product Code
    LOM
    Generic Name
    Test, hepatitis b (b core, be antigen, be antibody, b core igm)
    Medical Specialty
    Unknown
    Advisory Committee
    Microbiology
    Decision
    Approved
    Decision Code
    APPR
    Decision Date
    August 16, 2017
    Date Received
    February 21, 2017
    Supplement Type
    Normal 180 Day Track
    Supplement Reason
    Change Design/Components/Specifications/Material
    Expedited Review
    N

    Advisory Committee Statement

    Approval for 1) the inclusion of a second antigen source for the recombinant hepatitis B core antigen used in Reagent 1 of the test kit; 2) an update in the device by changing the standardization traceability to the World Health Organization Standard NIBSC 95/522; 3) extension of the reagent rackpack onboard stability from 4 weeks to 8 weeks; 4) addition of K3-EDTA plasma as a specimen type; and 5) modification of the device name.

    Classifications

    This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

    Product Code Device Name
    LOM Test, Hepatitis B (B Core, Be Antigen, Be Antibody, B Core Igm)